Cited by 166Neuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and TreatmentsParkinson's Disease Mechanisms and Treatments

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways

Open access

Santa-Cecília, Flávia V., Socias, Benjamin, Ouidja, Mohand O., Sepulveda-Diaz, Julia E., Acuña, Leonardo, Silva, Rangel L., Michel, Patrick P., Del-Bel, Elaine, Cunha, Thiago M., Raisman-Vozari, Rita·2016·Neurotoxicity Research

DOI 10.1007/s12640-015-9592-2

Open this paper in CoChat — free account

Abstract

In neurodegenerative diseases, the inflammatory response is mediated by activated glial cells, mainly microglia, which are the resident immune cells of the central nervous system. Activated microglial cells release proinflammatory mediators and neurotoxic factors that are suspected to cause or exacerbate these diseases. We recently demonstrated that doxycycline protects substantia nigra dopaminergic neurons in an animal model of Parkinson's disease. This effect was associated with a reduction of microglial cell activation, which suggests that doxycycline may operate primarily as an anti-inflammatory drug. In the present study, we assessed the anti-inflammatory potential of doxycycline using lipopolysaccharide (LPS)-activated primary microglial cells in culture as a model of neuroinflammation. Doxycycline attenuated the expression of key activation markers in LPS-treated microglial cultures in a concentration-dependent manner. More specifically, doxycycline treatment lowered the expression of the microglial activation marker IBA-1 as well as the production of ROS, NO, and proinflammatory cytokines (TNF-α and IL-1β). In primary microglial cells, we also found that doxycycline inhibits LPS-induced p38 MAP kinase phosphorylation and NF-kB nuclear translocation. The present results indicate that the effect of doxycycline on LPS-induced microglial activation probably occurs via the modulation of p38 MAP kinase and NF-kB signaling pathways. These results support the idea that doxycycline may be useful in preventing or slowing the progression of PD and other neurodegenerative diseases that exhibit altered glia function.

Integrity signals

Registry

Crossref · 10.1007/s12640-015-9592-2

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Physiology of Microglia
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Cutting Edge: Toll-Like Receptor 4 (TLR4)-Deficient Mice Are Hyporesponsive to Lipopolysaccharide: Evidence for TLR4 as the Lps Gene Product
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Neuropathology of Parkinson's Disease
Forno, L. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,556
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200
Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Role of Pro-Inflammatory Cytokines Released from Microglia in Neurodegenerative Diseases
Smith, J. A., Das, A., Ray, S. K., & Banik, N. L. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.10.004 · Cited by 1,165
Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Neurodegenerative diseases and oxidative stress
Emerit, J., Edeas, M. A., & Bricaire, F. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.004 · Cited by 1,057
Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.
Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10193 · Cited by 959
The Role of Nuclear Factor-κ B in Cytokine Gene Regulation
Blackwell, T. S., & Christman, J. W. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.1.f132 · Cited by 957
Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia
Kim, W., Mohney, R. P., Wilson, B. C., Jeohn, G., Liu, B., & Hong, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 881
Microglia and neurodegeneration: The role of systemic inflammation
Cunningham, C. (2013) · Glia · doi:10.1002/glia.22350 · Cited by 769
Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia
Henry, C. J., Huang, Y., Wynne, A., Hanke, M., Himler, J., Bailey, M. T., Sheridan, J. F., & Godbout, J. P. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-15 · Cited by 678
Methods for detection of reactive metabolites of oxygen and nitrogen: In vitro and in vivo considerations
Tarpey, M. M., Wink, D. A., & Grisham, M. B. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00361.2003 · Cited by 673
The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines
Austin, P. J., & Moalem-Taylor, G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.013 · Cited by 607
Enhanced Expression of Iba1, Ionized Calcium-Binding Adapter Molecule 1, After Transient Focal Cerebral Ischemia In Rat Brain
Ito, D., Tanaka, K., Suzuki, S., Dembo, T., & Fukuuchi, Y. (2001) · Stroke · doi:10.1161/01.str.32.5.1208 · Cited by 598
Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines
Henry, C. J., Huang, Y., Wynne, A. M., & Godbout, J. P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.09.002 · Cited by 565
The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 550
Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins
Butterfield, D. A., & Kański, J. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00249-4 · Cited by 420
Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
Zhang, Y., Dawson, V. L., & Dawson, T. M. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0319 · Cited by 408
Safety of doxycycline and minocycline: A systematic review
Smith, K., & Leyden, J. J. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.09.005 · Cited by 354
Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?
Hirsch, É. C., Hunot, S., Damier, P., & Faucheux, B. A. (1998) · Annals of Neurology · doi:10.1002/ana.410440717 · Cited by 334
Multiple Regulatory Elements in the Interleukin-6 Gene Mediate Induction by Prostaglandins, Cyclic AMP, and Lipopolysaccharide
Dendorfer, U., Oettgen, P., & Libermann, T. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4443 · Cited by 331
Tetracycline Therapy: Update
Roberts, M. C. (2003) · Clinical Infectious Diseases · doi:10.1086/367622 · Cited by 295
The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer’s and Parkinson’s diseases1,2 11Guest Editors: Mark A. Smith and George Perry 22This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found on the homepage of the journal.
Giasson, B. I., Ischiropoulos, H., Lee, V. M. ‐., & Trojanowski, J. Q. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00804-3 · Cited by 285
Pathogenic role of glial cells in Parkinson's disease
Teismann, P., Tieu, K., Cohen, O. S., Choi, D., Wu, D. C., Marks, D., Vila, M., Jackson-Lewis, V. R., & Przedborski, S. (2002) · Movement Disorders · doi:10.1002/mds.10332 · Cited by 276
Differential migration, LPS‐induced cytokine, chemokine, and NO expression in immortalized BV‐2 and HAPI cell lines and primary microglial cultures
Horvath, R. J., Nutile‐McMenemy, N., Alkaitis, M. S., & DeLeo, J. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05633.x · Cited by 264
Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson’s Disease
More, S. V., Kumar, H., Kim, I. S., Song, S.-Y., & Choi, D.-K. (2013) · Mediators of Inflammation · doi:10.1155/2013/952375 · Cited by 264
Review: Role of developmental inflammation and blood–brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases
Stolp, H. B., & Dzięgielewska, K. M. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01005.x · Cited by 263
Mast cells, glia and neuroinflammation: partners in crime?
Skaper, S. D., Facci, L., & Giusti, P. (2013) · Immunology · doi:10.1111/imm.12170 · Cited by 257
Molecular pathogenesis of Parkinson's disease
Gandhi, S., & Wood, N. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi308 · Cited by 251
Neuroimmunological Processes in Parkinson’s Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity
Sánchez-Guajardo, V., Barnum, C. J., Tansey, M. G., & Romero‐Ramos, M. (2013) · ASN NEURO · doi:10.1042/an20120066 · Cited by 246
The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
Dutta, G., Zhang, P., & Liu, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00616.x · Cited by 235 · cited 16×
“The results showed that doxycycline reduced the production of ROS and completely abolished the production of NO induced by LPS.”
BackgroundInfluential
Microglia and mast cells: two tracks on the road to neuroinflammation
Skaper, S. D., Giusti, P., & Facci, L. (2012) · The FASEB Journal · doi:10.1096/fj.11-197194 · Cited by 235
Neuromelanin can protect against iron‐mediated oxidative damage in system modeling iron overload of brain aging and Parkinson’s disease
Zecca, L., Casella, L., Albertini, A., Bellei, C., Zucca, F. A., Engelen, M., Żądło, A. C., Szewczyk, G. M., Zaręba, M., & Sarna, T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05541.x · Cited by 233
The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions
Lund, S., Christensen, K. V., Hedtjärn, M., Mortensen, A. L., Hagberg, H., Falsig, J., Hasseldam, H., Schrattenholz, A. S., Pörzgen, P., & Leist, M. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.07.007 · Cited by 217
Neuroprotection by tetracyclines
Domercq, M., & Matute, C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.10.001 · Cited by 205
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Russo, I., Bubacco, L., & Greggio, E. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-52 · Cited by 192
Minocycline exerts inhibitory effects on multiple mitogen‐activated protein kinases and IκBα degradation in a stimulus‐specific manner in microglia
Nikodémová, M., Duncan, I. D., & Watters, J. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03520.x · Cited by 176
Minocycline reduces gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis
Metz, L. M., Zhang, Y., Yeung, M., Patry, D. G., Bell, R. B., Stoian, C. A., Yong, V. W., Patten, S. B., Duquette, P., Antel, J. P., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20111 · Cited by 171
Doxycycline Alters Metabolism and Proliferation of Human Cell Lines
Ahler, E., Sullivan, W. J., Cass, A. A., Braas, D., York, A. G., Bensinger, S. J., Graeber, T. G., & Christofk, H. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064561 · Cited by 170
Microglia change from a reactive to an age-like phenotype with the time in culture
Caldeira, C., Oliveira, A. F., Cunha, C., Vaz, A. R., FalcÃ£o, A. S., Fernandes, A., & Brites, D. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00152 · Cited by 156
The p38 MAP Kinase Family as Regulators of Proinflammatory Cytokine Production in Degenerative Diseases of the CNS.
Bachstetter, A. D., & Eldik, L. J. V. (2010) · PubMed Central · Cited by 155
Macrophage Deletion of p38α Partially Impairs Lipopolysaccharide-Induced Cellular Activation
Kang, Y. J., Chen, J., Otsuka, M., Mols, J., Ren, S. V., Wang, Y., & Han, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.5075 · Cited by 154
Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseases
Roy, A., Jana, A., Yatish, K., Freidt, M. B., Fung, Y. K., Martinson, J., & Pahan, K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.026 · Cited by 139
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis
Gordon, P. H., Moore, D. H., Gelinas, D. F., Qualls, C., Meister, M. E., Werner, J., Mendoza, M., Mass, J., Kushner, G., & Miller, R. G. (2004) · Neurology · doi:10.1212/01.wnl.0000125321.92112.7e · Cited by 139
Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis
Yim, C. W., Flynn, N. M., & Fitzgerald, F. T. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.2.347 · Cited by 133
Effect of bacterial wall lipopolysaccharide (LPS) on morphology, motility, and cytoskeletal organization of microglia in cultures
Abd‐El‐Basset, E. M., & FEDOROFF, S. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410210 · Cited by 123
Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease
Bortolanza, M., Cavalcanti-Kwiatkoski, R., Padovan‐Neto, F. E., da-Silva, C. A., Mitkovski, M., Raisman‐Vozari, R., & Bel, E. A. D. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.017 · Cited by 122
Doxycycline restrains glia and confers neuroprotection in a 6‐OHDA Parkinson model
Lazzarini, M., Martin, S., Mitkovski, M., Raisman‐Vozari, R., Stühmer, W., & Bel, E. D. (2013) · Glia · doi:10.1002/glia.22496 · Cited by 119
Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain
Fan, L.-W., Pang, Y., Lin, S., Rhodes, P. G., & Cai, Z. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.02.016 · Cited by 118
Exogenous corticosterone reduces l-DOPA-induced dyskinesia in the hemi-parkinsonian rat: Role for interleukin-1β
Barnum, C. J., Jaunarajs, K. L. E., Dupre, K. B., Blandino, P., Terrence Deak, B., & Bishop, C. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.016 · Cited by 113
Minocycline in Huntington's disease: A pilot study
Thomas, M., Ashizawa, T., & Jankovic, J. J. (2004) · Movement Disorders · doi:10.1002/mds.20018 · Cited by 111
Multiple Regulatory Elements in the Interleukin-6 Gene Mediate Induction by Prostaglandins, Cyclic AMP, and Lipopolysaccharide
Dendorfer, U., Oettgen, P., & Libermann, T. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4443-4454.1994 · Cited by 89
Doxycycline Is Neuroprotective Against Nigral Dopaminergic Degeneration by a Dual Mechanism Involving MMP-3
Cho, Y., Son, H. J., Kim, E.-M., Choi, J. H., Kim, S. T., Ji, I. J., Choi, D. H., Joh, T. H., Kim, Y. S., & Hwang, O. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9078-1 · Cited by 85
Inhibitory action of minocycline on lipopolysaccharide-lnduced release of nitric oxide and prostaglandin E2 in BV2 microglial cells
Kim, S., Kong, P., Kim, B.-S., Sheen, D., Nam, S.-Y., & Chun, W. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980066 · Cited by 81
Microglial cells in neurodegenerative disorders.
Wojtera, M., Sikorska, B., Sobów, T., & Liberski, P. P. (2005) · PubMed · Cited by 78
Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1
Bosscher, K. D., Beck, I. M. E., Dejager, L., Bougarne, N., Gaigneaux, A., Chateauvieux, S., Ratman, D., Bracke, M., Tavernier, J. H., Berghe, W. V., et al. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1367-4 · Cited by 75
Doxycycline treatment reduces ischemic brain damage in transient middle cerebral artery occlusion in the rat
Clark, W. M., Lessov, N. S., Lauten, J. D., & Hazel, K. (1997) · Journal of Molecular Neuroscience · doi:10.1007/bf02736854 · Cited by 48
The Tetracyclines
Cunha, B. A., Comer, J. B., & Jonas, M. (1982) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31461-4 · Cited by 46
Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment.
Clark, W. M., Calcagno, F. A., Gabler, W. L., Smith, J. R. L., & Coull, B. M. (1994) · Stroke · doi:10.1161/01.str.25.7.1411 · Cited by 44
Isolation and Characterization of Microglia from Adult Mouse Brain: Selected Applications for ex Vivo Evaluation of Immunotoxicological Alterations Following in Vivo Xenobiotic Exposure
Singh, V., Mitra, S., Sharma, A. K., Gera, R., & Ghosh, D. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500046k · Cited by 41
Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: Does variable inhibition of interleukin‐6 production limit effectiveness in vivo?
Page, T. H., Brown, A., Timms, E. M., Foxwell, B. M. J., & Ray, K. P. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27631 · Cited by 37
Peripheral injection of lipopolysaccharide enhances expression of inflammatory cytokines in murine locus coeruleus: possible role of increased norepinephrine turnover
Kaneko, Y. S., Mori, K., Nakashima, A., Sawada, M., Nagatsu, I., & Ota, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03209.x · Cited by 33
Doxycycline Reduces Early Neurologic Impairment after Cerebral Arterial Air Embolism in the Rabbit
Reasoner, D. K., Hindman, B. J., Dexter, F., Subieta, A. R., Cutkomp, J., & Smith, T. (1997) · Anesthesiology · doi:10.1097/00000542-199709000-00017 · Cited by 30
COL-3, a Chemically Modified Tetracycline, Inhibits Lipopolysaccharide-Induced Microglia Activation and Cytokine Expression in the Brain
Edan, R. A., Luqmani, Y. A., & Masocha, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057827 · Cited by 28
The p38 MAPK inhibitor SB203580 differentially modulates LPS-induced interleukin 6 expression in macrophages
Shi, Q., Cheng, L., Liu, Z., Hu, K., Ran, J., Ge, D., & Fu, J. (2015) · Central European Journal of Immunology · doi:10.5114/ceji.2015.54586 · Cited by 28
A novel synthetic HTB derivative, BECT inhibits lipopolysaccharide-mediated inflammatory response by suppressing the p38 MAPK/JNK and NF-κB activation pathways
Kang, S.-M., More, S. V., Park, J., Kim, B.-W., In, P. J., Yoon, S., & Choi, D. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.08.015 · Cited by 27
Doxycycline up-regulates the expression of IL-6 and GM-CSF via MAPK/ERK and NF-κB pathways in mouse thymic epithelial cells
Huang, Y., Li, R., Chen, X., Zhuo, Y., Jin, R., Qian, X. P., Jiang, Y. Q., Zeng, Z. H., Zhang, Y., & Shao, Q. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.03.011 · Cited by 12
Study on the Dynamic Changes in Synaptic Vesicle-Associated Protein and Axonal Transport Protein Combined with LPS Neuroinflammation Model
Zhang, R., Zhao, M., Ji, H., Yuan, Y., & Chen, N. (2013) · ISRN Neurology · doi:10.1155/2013/496079 · Cited by 9
[Protective effects of doxycycline upon dopaminergic neuron in LPS-induced rat model of Parkinson's disease].
Wang, P., Sun, S., & Qiao, X. (2009) · PubMed · Cited by 2
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1

Flagged first, then by citations

Sorted by citations

Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease
Sun, M.-F., & Shen, Y.-Q. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.004 · Cited by 445
Clinical-grade stem cell–derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs
Sharma, R., Khristov, V., Rising, A. C., Jha, B. S., Dejene, R., Hotaling, N. A., Li, Y., Stoddard, J., Stankewicz, C., Wan, Q., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat5580 · Cited by 367
Microglia in the Retina: Roles in Development, Maturity, and Disease
Silverman, S. M., & Wong, W. T. (2018) · Annual Review of Vision Science · doi:10.1146/annurev-vision-091517-034425 · Cited by 364
Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach
Singh, S., & Singh, T. G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200207120949 · Cited by 307
CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
Walens, A., DiMarco, A. V., Lupo, R., Kroger, B. R., Damrauer, J. S., & Alvarez, J. V. (2019) · eLife · doi:10.7554/elife.43653 · Cited by 205

See all 166

Authors: Santa-Cecília, F. V., Socias, B., Ouidja, M. O., Sepulveda-Diaz, J. E., Acuña, L., Silva, R. L., Michel, P. P., Del-Bel, E., Cunha, T. M., & Raisman-Vozari, R.
Affiliations: Centre National de la Recherche Scientifique (FR)
National University of Tucumán (AR)
Universidade de São Paulo (BR)
ORCID: Ouidja, Mohand O.
Sepulveda-Diaz, Julia E.
Acuña, Leonardo
Silva, Rangel L.
Michel, Patrick P.
Cunha, Thiago M.
Venue: Neurotoxicity Research
Publisher: Springer Science and Business Media LLC
Published: 2016-01-08
Volume: 29
Issue: 4
Pages: 447-459
ISSN: 1029-8428 (ISSN-L)
1476-3524
DOI: 10.1007/s12640-015-9592-2
OpenAlex: W2232460448
Cited by: 165
References: 81
Citations by year: 2026: 11 · 2025: 9 · 2024: 12 · 2023: 15 · 2022: 31 · 2021: 29 · 2020: 17 · 2019: 13 · 2018: 14 · 2017: 12 · 2016: 2
FWCI: 7.49
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: cc-by-nc-sa
www.springer.com/tdm (tdm)
Locations: Neurotoxicity Research (publishedVersion)
PubMed (publishedVersion)
CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
Funders: MINCyT-ECOS Program (A12S02)
Fundação de Amparo à Pesquisa do Estado de São Paulo (2011/19670-0, 2013/08216-2)
Investissements d’avenir (ANR-10-IAIHU-06)
Translational Research Infrastructure for Biotherapies in Neurosciences (ANR-11-INBS-0011-NeurATRIS)
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords: doxycycline, microglial activation, neuroinflammation, p38 MAPK, NF-κB signaling, lipopolysaccharide, Parkinson's disease, anti-inflammatory activity, Iba1, reactive oxygen species, nitric oxide, TNF-α, IL-1β, substantia nigra dopaminergic neurons, neurodegenerative diseases
MeSH terms: Nucleophosmin, Animals, Anti-Bacterial Agents, Brain, Calcium-Binding Proteins, Cell Survival, Cells, Cultured, Doxycycline, Drug Interactions, Glial Fibrillary Acidic Protein, Lipopolysaccharides, Microfilament Proteins, Nitric Oxide, Nuclear Proteins, Signal Transduction, Macrophage-1 Antigen, Cytokines, NF-kappa B, Reactive Oxygen Species, Microglia, p38 Mitogen-Activated Protein Kinases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks